azathioprine has been researched along with Periodontal Pocket in 3 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Periodontal Pocket: An abnormal extension of a gingival sulcus accompanied by the apical migration of the epithelial attachment and bone resorption.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of this study was to determine the incidence and severity of gingival overgrowth (GO) induced by tacrolimus (Tcr) compared with ciclosporin A (CiA) in the absence of calcium channel blockers (CCB) in renal transplant recipients." | 7.74 | Incidence of tacrolimus-induced gingival overgrowth in the absence of calcium channel blockers: a short-term study. ( Lotufo, RF; Paixão, CG; Pannuti, CM; Romito, GA; Saraiva, L; Sekiguchi, RT, 2007) |
"The factors associated with cyclosporin A (CsA)- and nifedipine (Nif)-induced gingival overgrowth were investigated in 113 renal transplant recipients receiving CsA alone (Group 1) [n = 61], CsA and Nif (Group 2) [n = 28], or azathioprine (Aza) (Control Group) [n = 24]." | 7.69 | Cyclosporin- and nifedipine-induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters, and HLA-antigens. ( Barbaro, A; Margiotta, V; Pizzo, G; Pizzo, I, 1996) |
"The aim of this study was to determine the incidence and severity of gingival overgrowth (GO) induced by tacrolimus (Tcr) compared with ciclosporin A (CiA) in the absence of calcium channel blockers (CCB) in renal transplant recipients." | 3.74 | Incidence of tacrolimus-induced gingival overgrowth in the absence of calcium channel blockers: a short-term study. ( Lotufo, RF; Paixão, CG; Pannuti, CM; Romito, GA; Saraiva, L; Sekiguchi, RT, 2007) |
"The factors associated with cyclosporin A (CsA)- and nifedipine (Nif)-induced gingival overgrowth were investigated in 113 renal transplant recipients receiving CsA alone (Group 1) [n = 61], CsA and Nif (Group 2) [n = 28], or azathioprine (Aza) (Control Group) [n = 24]." | 3.69 | Cyclosporin- and nifedipine-induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters, and HLA-antigens. ( Barbaro, A; Margiotta, V; Pizzo, G; Pizzo, I, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sekiguchi, RT | 1 |
Paixão, CG | 1 |
Saraiva, L | 1 |
Romito, GA | 1 |
Pannuti, CM | 1 |
Lotufo, RF | 1 |
Margiotta, V | 1 |
Pizzo, I | 1 |
Pizzo, G | 1 |
Barbaro, A | 1 |
Rahman, MM | 1 |
Caglayan, F | 1 |
Rahman, B | 1 |
3 other studies available for azathioprine and Periodontal Pocket
Article | Year |
---|---|
Incidence of tacrolimus-induced gingival overgrowth in the absence of calcium channel blockers: a short-term study.
Topics: Adult; Anti-Infective Agents; Azathioprine; Calcium Channel Blockers; Cyclosporine; Dental Plaque In | 2007 |
Cyclosporin- and nifedipine-induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters, and HLA-antigens.
Topics: Adolescent; Adult; Azathioprine; Calcium Channel Blockers; Child; Cyclosporine; Dental Calculus; Den | 1996 |
Periodontal health parameters in patients with chronic renal failure and renal transplants receiving immunosuppressive therapy.
Topics: Adult; Azathioprine; Cyclosporine; Dental Plaque Index; Female; Humans; Immunosuppressive Agents; Ki | 1992 |